CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

交易 10x Genomics, Inc. - TXG CFD

55.73
7.23%
0.14
最低: 53.18
最高: 56.09
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.14
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024874%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.002651%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 51.97
开盘价* 53.18
1 年变化* -28.68%
日范围* 53.18 - 56.09
52 周范围 23.81-83.34
平均交易量(10 天) 754.85K
平均交易量(3 个月) 21.21M
市值 6.00B
市盈率 -100.00K
流通股 115.36M
收入 516.41M
EPS -1.46
股息(收益率 %) N/A
贝塔 1.74
下一个财报发布日期 May 2, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 31, 2023 55.73 3.30 6.29% 52.43 56.16 52.01
Mar 30, 2023 51.97 0.76 1.48% 51.21 52.32 51.07
Mar 29, 2023 50.69 1.41 2.86% 49.28 50.98 49.00
Mar 28, 2023 48.81 -0.45 -0.91% 49.26 49.42 48.27
Mar 27, 2023 49.70 -0.68 -1.35% 50.38 51.52 49.29
Mar 24, 2023 50.12 2.16 4.50% 47.96 50.30 47.65
Mar 23, 2023 48.97 0.03 0.06% 48.94 51.49 48.48
Mar 22, 2023 48.69 -1.39 -2.78% 50.08 51.08 48.61
Mar 21, 2023 50.03 1.83 3.80% 48.20 50.25 47.91
Mar 20, 2023 47.76 0.30 0.63% 47.46 48.56 46.76
Mar 17, 2023 48.08 -1.09 -2.22% 49.17 49.71 47.66
Mar 16, 2023 50.25 2.49 5.21% 47.76 50.90 47.60
Mar 15, 2023 48.54 1.45 3.08% 47.09 49.32 47.08
Mar 14, 2023 48.63 0.07 0.14% 48.56 49.52 48.06
Mar 13, 2023 47.44 3.47 7.89% 43.97 49.32 43.97
Mar 10, 2023 44.93 -1.55 -3.33% 46.48 46.49 43.15
Mar 9, 2023 47.00 -1.65 -3.39% 48.65 49.98 46.93
Mar 8, 2023 48.95 1.16 2.43% 47.79 49.49 47.24
Mar 7, 2023 48.16 0.10 0.21% 48.06 49.75 47.48
Mar 6, 2023 48.39 -2.30 -4.54% 50.69 50.80 48.13

10x Genomics, Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 516.409 490.49 298.845 245.893 146.313
收入 516.409 490.49 298.845 245.893 146.313
收入成本,共计 120.386 74.091 58.468 61.033 28.661
毛利 396.023 416.399 240.377 184.86 117.652
总营业费用 684.353 542.743 834.508 276.466 257.077
销售/一般/行政费用,总计 298.3 257.56 199.726 130.834 87.936
研究与开发 265.667 211.752 570.923 83.097 109.9
Other Operating Expenses, Total 0 -0.66 1.27 1.502 30.58
营业收入 -167.944 -52.253 -535.663 -30.573 -110.764
利息收入(费用),非经营净值 6.171 -0.66 -0.15 -0.274 -1.385
其他,净值 -0.198 -0.802 1.337 -0.186 -0.249
税前净收入 -161.971 -53.715 -534.476 -31.033 -112.398
税后净收入 -166 -58.223 -542.731 -31.251 -112.485
未计算非常项目前的净收益 -166 -58.223 -542.731 -31.251 -112.485
非常规项目总计
净收入 -166 -58.223 -542.731 -31.251 -112.485
普通股股东可获收益 (不含非经常性项目) -166 -58.223 -542.731 -31.251 -112.485
普通股股东可获收益 (含非經常性項目) -166 -58.223 -542.731 -31.251 -112.485
摊薄净收入 -166 -58.223 -542.731 -31.251 -112.485
摊薄后加权平均股 113.859 110.348 101.152 96.2416 93.8497
扣除特别项目的每股摊薄盈利 -1.45795 -0.52763 -5.36552 -0.32471 -1.19857
每股正常摊薄盈利 -1.45795 -0.52763 -5.33904 -0.32471 -1.19857
异常费用(收入) 0 0 4.121
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
总收入 156.232 131.072 114.609 114.496 143.53
收入 156.232 131.072 114.609 114.496 143.53
收入成本,共计 36.827 30.377 27.704 25.478 27.598
毛利 119.405 100.695 86.905 89.018 115.932
总营业费用 179.328 171.068 177.726 156.231 159.36
销售/一般/行政费用,总计 78.887 73.401 79.337 66.675 69.877
研究与开发 63.614 67.29 70.685 64.078 61.885
异常费用(收入) 0 0
Other Operating Expenses, Total 0 0 0 0
营业收入 -23.096 -39.996 -63.117 -41.735 -15.83
利息收入(费用),非经营净值 2.69 1.911 1.129 0.441 -0.168
其他,净值 3.995 -1.95 -1.843 -0.4 0.005
税前净收入 -16.411 -40.035 -63.831 -41.694 -15.993
税后净收入 -17.215 -41.914 -64.458 -42.413 -18.449
未计算非常项目前的净收益 -17.215 -41.914 -64.458 -42.413 -18.449
净收入 -17.215 -41.914 -64.458 -42.413 -18.449
普通股股东可获收益 (不含非经常性项目) -17.215 -41.914 -64.458 -42.413 -18.449
普通股股东可获收益 (含非經常性項目) -17.215 -41.914 -64.458 -42.413 -18.449
摊薄净收入 -17.215 -41.914 -64.458 -42.413 -18.449
摊薄后加权平均股 114.767 114.112 113.575 112.966 111.913
扣除特别项目的每股摊薄盈利 -0.15 -0.3673 -0.56754 -0.37545 -0.16485
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常摊薄盈利 -0.15 -0.3673 -0.56754 -0.37545 -0.16485
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 747.591 774.366 480.84 106.236 68.107
现金和短期投资 587.447 663.603 424.166 65.08 47.857
现金等价物 587.447 663.603 424.166 65.08 47.857
应收账款总额,净额 85.254 51.208 33.371 29.566 13.341
Accounts Receivable - Trade, Net 85.254 51.208 33.371 28.088 13.341
Total Inventory 59.966 29.959 15.27 8.57 4.838
Prepaid Expenses 13.896 13.029 8.033 3.02 2.071
Total Assets 1018.83 929.341 605.923 124.31 75.609
Property/Plant/Equipment, Total - Net 230.41 119.823 48.821 11.127 6.925
Property/Plant/Equipment, Total - Gross 279.431 150.325 67.876 25.21 17.958
Accumulated Depreciation, Total -49.021 -30.502 -19.055 -14.083 -11.033
Other Long Term Assets, Total 10.917 12.798 76.262 6.947 0.577
Total Current Liabilities 110.357 118.126 63.049 32.362 22.141
Accounts Payable 17.351 4.709 13.028 8.792 5.443
Accrued Expenses 75.821 92.326 30.035 12.118 8.959
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 9.882 4.187 4.224
Other Current Liabilities, Total 17.185 21.091 10.104 7.265 3.515
Total Liabilities 201.258 190.269 185.84 101.053 29.704
Total Long Term Debt 0 0 19.837 25.489 6.335
Long Term Debt 0 19.837 25.489 6.335
Other Liabilities, Total 90.901 72.143 102.954 43.202 1.228
Total Equity 817.568 739.072 420.083 23.257 45.905
Redeemable Preferred Stock 0 243.244 158.414
Common Stock 0.002 0.002 0.002 0.001 0.001
Additional Paid-In Capital 1680.86 1544.22 682.494 11.165 6.136
Retained Earnings (Accumulated Deficit) -863.321 -805.098 -262.367 -231.116 -118.631
Other Equity, Total 0.022 -0.05 -0.046 -0.037 -0.015
Total Liabilities & Shareholders’ Equity 1018.83 929.341 605.923 124.31 75.609
Total Common Shares Outstanding 112.515 108.486 96.2416 93.8497 93.8497
Other Current Assets, Total 1.028 16.567
Intangibles, Net 25.397 22.354
Goodwill, Net 4.511
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 697.335 747.591 744.104 757.174 745.716
现金和短期投资 539.323 587.447 600.44 621.958 617.195
现金等价物 312.487 587.447 600.44 621.958 617.195
应收账款总额,净额 76.526 85.254 78.43 59.68 57.408
Accounts Receivable - Trade, Net 76.526 85.254 78.43 59.68 57.408
Total Inventory 63.697 59.966 51.141 44.087 38.507
Prepaid Expenses 17.762 13.896 14.065 13.298 14.442
Other Current Assets, Total 0.027 1.028 0.028 18.151 18.164
Total Assets 1003.25 1018.83 990.572 977.579 954.033
Property/Plant/Equipment, Total - Net 265.88 230.41 203.304 176.454 163.666
Property/Plant/Equipment, Total - Gross 279.431 247.698 215.665 198.415
Accumulated Depreciation, Total -49.021 -44.394 -39.211 -34.749
Goodwill, Net 4.511 4.511 4.511 4.511 4.511
Intangibles, Net 24.764 25.397 26.041 26.693 27.342
Other Long Term Assets, Total 10.761 10.917 12.612 12.747 12.798
Total Current Liabilities 94.446 110.357 100.375 113.126 120.549
Accounts Payable 18.956 17.351 17.037 16.181 15.578
Accrued Expenses 59.913 75.821 69.92 85.598 95.307
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 15.577 17.185 13.418 11.347 9.664
Total Liabilities 196.566 201.258 190.351 192.993 201.573
Total Long Term Debt 0 0 0 0 0
Long Term Debt 0
Other Liabilities, Total 102.12 90.901 89.976 79.867 81.024
Total Equity 806.685 817.568 800.221 784.586 752.46
Common Stock 0.002 0.002 0.002 0.002 0.002
Additional Paid-In Capital 1714.86 1680.86 1644.9 1612.23 1569.06
Retained Earnings (Accumulated Deficit) -905.734 -863.321 -844.872 -827.701 -816.649
Other Equity, Total -2.443 0.022 0.194 0.058 0.048
Total Liabilities & Shareholders’ Equity 1003.25 1018.83 990.572 977.579 954.033
Total Common Shares Outstanding 113.276 112.515 111.537 110.74 109.589
短期投资 226.836
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -58.223 -542.731 -31.251 -112.485 -18.762
经营活动产生的现金 -21.373 -217.898 34.627 -76.409 -10.699
经营活动产生的现金 21.118 14.012 7.066 3.905 4.305
非现金物品 103.177 361.202 14.048 4.156 1.81
Cash Taxes Paid 8.66 0.28 -0.022 -0.006 0
已付现金利息 1.222 1.67 2.25 1.824 0.658
营运资金的变化 -87.445 -50.381 44.764 28.015 1.948
投资活动产生的现金 -106.729 -38.394 -42.767 -6.709 -3.756
资本支出 -101.278 -38.394 -42.767 -6.709 -3.756
融资活动产生的现金 35.297 468.906 414.59 105.367 20.583
融资现金流项目 -5.028 -5.848 0 0
股票的发行(报废),净额 40.325 506.01 414.59 86.628 20.976
债务的发行(退还),净额 0 -31.256 0 18.739 -0.393
外汇效应 0.234 -0.463 -0.045 -0.018 -0.014
现金净变化 -92.571 212.151 406.405 22.231 6.114
其他投资现金流量项目,总计 -5.451
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -42.413 -58.223 -39.774 -22.603 -11.551
Cash From Operating Activities -20.802 -21.373 -27.178 -0.962 -4.082
Cash From Operating Activities 6.191 21.118 15.337 9.641 4.752
Non-Cash Items 28.014 103.177 74.717 47.188 17.922
Cash Taxes Paid 2.9 8.66 8.318 7.838 6.822
Cash Interest Paid 0.841 1.222 1.222 1.222 1.222
Changes in Working Capital -12.594 -87.445 -77.458 -35.188 -15.205
Cash From Investing Activities -257.558 -106.729 -79.111 -58.884 -44.316
Capital Expenditures -28.136 -101.278 -73.66 -53.433 -38.865
Other Investing Cash Flow Items, Total -229.422 -5.451 -5.451 -5.451 -5.451
Cash From Financing Activities 2.417 35.297 26.394 19.711 3.518
Financing Cash Flow Items -5.409 -5.028 -5.028 -5.028 -5.028
Issuance (Retirement) of Stock, Net 7.826 40.325 31.422 24.739 8.546
Issuance (Retirement) of Debt, Net 0 0 0 0
Foreign Exchange Effects -0.018 0.234 0.316 0.199 0.193
Net Change in Cash -275.961 -92.571 -79.579 -39.936 -44.687
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Morgan Stanley Investment Management Inc. (US) Investment Advisor/Hedge Fund 9.4813 9210082 -415196 2022-12-31 LOW
Baillie Gifford & Co. Investment Advisor 8.8556 8602235 158847 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.6523 8404774 145652 2022-12-31 LOW
Paladin Capital Management, LLC Investment Advisor 8.3511 8112208 0 2022-03-31
ARK Investment Management LLC Investment Advisor 4.4437 4316567 -260247 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.3422 4217954 207975 2022-12-31 LOW
Sands Capital Management, LLC Investment Advisor 3.3012 3206783 -184394 2022-12-31 LOW
Fidelity Management & Research Company LLC Investment Advisor 3.2549 3161803 -518131 2022-12-31 LOW
SRS Investment Management, LLC Hedge Fund 3.0939 3005427 0 2022-12-31 LOW
Generation Investment Management LLP Investment Advisor/Hedge Fund 2.6231 2548100 -57577 2022-12-31 LOW
Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund 2.2421 2177988 -29270 2022-12-31 LOW
Credit Suisse Asset Management Investment Advisor/Hedge Fund 2.1979 2135038 -17833 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 2.018 1960300 -337642 2022-12-31 LOW
Citadel Advisors LLC Hedge Fund 1.507 1463901 1108820 2022-12-31 HIGH
Brown Capital Management, LLC Investment Advisor 1.4964 1453630 -161463 2022-12-31 LOW
Foresite Capital Management, LLC Private Equity 1.3985 1358528 -1145000 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3854 1345749 -18168 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.3601 1321234 63324 2022-12-31 LOW
Millennium Management LLC Hedge Fund 1.2491 1213394 999487 2022-12-31 HIGH
JP Morgan Asset Management Investment Advisor 1.2158 1180996 27291 2022-12-31 LOW

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

10x Genomics, Inc. Company profile

关于 10X Genomics Inc

10x Genomics, Inc.是一家生命科学技术公司。 公司的综合解决方案包括用于分析生物系统的仪器、消耗品和软件。 其产品包括Chromium单细胞基因表达,单细胞免疫分析,转座酶可及染色质(ATAC)+基因表达的单细胞检测,单细胞ATAC,空间基因表达,空间多组学,以及靶向基因表达。 其仪器包括Chromium X系列,Chromium Connect,和Chromium Controller。 其技术 下一个GEM技术,包括芯片和兼容试剂,提供给单细胞产品组合。 其耗材组合包括微流控芯片、玻片、试剂和其他耗材,用于其Visium和Chromium解决方案。 公司的应用包括簇状规则间隔短回文重复序列(CRISPR)筛查、多原子细胞测量和免疫受体绘图。

Industry: Laboratory Diagnostic & Testing Substances

6230 Stoneridge Mall Road
PLEASANTON
CALIFORNIA 94588
US

收入报表

  • Annual
  • Quarterly

人们也观看

Gold

1,969.66 Price
-0.550% 1D Chg, %
多头隔夜费 -0.0185%
空头隔夜费 0.0102%
隔夜费时间 21:00 (UTC)
价差 0.30

US100

13,186.80 Price
+1.680% 1D Chg, %
多头隔夜费 -0.0249%
空头隔夜费 0.0027%
隔夜费时间 21:00 (UTC)
价差 3.0

BTC/USD

28,554.80 Price
+0.470% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 60.00

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
多头隔夜费 -0.0156%
空头隔夜费 -0.0063%
隔夜费时间 21:00 (UTC)
价差 0.03

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易